Home
About
Overview
Sharing Data
ORCID
Help
History (9)
The future of computer-assisted surgery (CAS) in sports medicine.
The in vivo metabolism of somatostatin 28: possible relationship between diminished metabolism and enhanced biological action.
Major corrections are indicated for 'Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia'.
Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes.
The future of pharmacogenetics in the treatment of hypertension.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The future of pharmacogenetics in the treatment of hypertension.
The future of pharmacogenetics in the treatment of hypertension. Pharmacogenomics. 2019 02; 20(3):129-132.
View in:
PubMed
subject areas
Adrenergic beta-Antagonists
Antihypertensive Agents
Blood Pressure
Calcium Channel Blockers
Humans
Hypertension
Pharmacogenetics
Polymorphism, Single Nucleotide
authors with profiles
Patrick Cunningham
Arlene Chapman